GE Healthcare Technologies Inc（股票代码：GEHC）今日盘中大涨5.04%，引发市场关注。
据英国《金融时报》报道，由强生公司支持的医疗技术公司HistoSonics正在探讨以超过25亿美元的估值出售。报道称，GE Healthcare、美敦力和强生公司正在评估这项业务。这一消息可能是推动GE Healthcare股价上涨的主要原因。
HistoSonics公司开发了一种针对肝脏肿瘤的创新声波束疗法，具有较高的医疗技术价值。据报道，该公司此前曾考虑上市，但由于市场波动影响了首次公开募股计划，现在优先考虑出售。花旗集团正在为HistoSonics的出售提供咨询。预计未来几周内将有最终的出价，但交易尚无保证。如果GE Healthcare成功收购HistoSonics，将有助于扩大其在医疗技术领域的业务范围，这可能是投资者看好的原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.